Relief Therapeutics Holding SA logo

Relief Therapeutics Holding SA - ADR

NEW
OTCPK:RLFTY (Switzerland)   ADR
$ 3.3 +0.43 (+14.98%) 12:08 AM EST
At Loss
P/B:
0.80
Market Cap:
$ 41.38M
Enterprise V:
$ 27.68M
Volume:
410.00
Avg Vol (2M):
643.00
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
410.00
At Loss
Avg Vol (2M):
643.00

Business Description

Description
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development such as RLF-TD011, and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast among others. Geographically the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.
Name Current Vs Industry Vs History
Cash-To-Debt 4.44
Equity-to-Asset 0.7
Debt-to-Equity 0.05
Debt-to-EBITDA -0.05
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.61
Distress
Grey
Safe
Beneish M-Score -1.79
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.09
Quick Ratio 3.01
Cash Ratio 2.25
Days Inventory 66.7
Days Sales Outstanding 44.57
Days Payable 216.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.6
Shareholder Yield % 1

Financials (Next Earnings Date:2025-03-17 Est.)

RLFTY's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:RLFTY

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Relief Therapeutics Holding SA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 9.725
EPS (TTM) ($) -4.171
Beta 0.95
3-Year Sharpe Ratio -0.14
3-Year Sortino Ratio -0.3
Volatility % 179.19
14-Day RSI 44.52
14-Day ATR ($) 0.273051
20-Day SMA ($) 3.5407
12-1 Month Momentum % 104.67
52-Week Range ($) 1.05 - 7.71
Shares Outstanding (Mil) 12.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Relief Therapeutics Holding SA Filings

Filing Date Document Date Form
No Filing Data

Relief Therapeutics Holding SA Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Relief Therapeutics Holding SA Frequently Asked Questions

What is Relief Therapeutics Holding SA(RLFTY)'s stock price today?
The current price of RLFTY is $3.30. The 52 week high of RLFTY is $7.71 and 52 week low is $1.05.
When is next earnings date of Relief Therapeutics Holding SA(RLFTY)?
The next earnings date of Relief Therapeutics Holding SA(RLFTY) is 2025-03-17 Est..
Does Relief Therapeutics Holding SA(RLFTY) pay dividends? If so, how much?
Relief Therapeutics Holding SA(RLFTY) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1